ClinicalTrials.Veeva

Menu

Museum Prescription by a Physician for a Visit to the MBAM (PM)

C

Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

Status

Completed

Conditions

Quality of Life
Social Isolation

Treatments

Other: Museum visit

Study type

Interventional

Funder types

Other

Identifiers

NCT05445453
MP-53-2023-2627

Details and patient eligibility

About

In recent years, museums have participated in the patient care journey by using art to enhance their quality of life and well-being. Since 2015, the Montreal Museum of Fine Arts (MMFA) and Dr. Beauchet have developed an Action-Research program exploring the effects of participatory art activities for community elders conducted at the MMFA, known as the Arts & Longevity Lab (ALL). The mandate of ALL is to improve the well-being, quality of life and health (i.e. mental and physical state) of individuals and patients through the practice of visual arts activities (i.e. arts that produce objects perceived by the eyes).

Since 2019, the MMFA has developed in collaboration with Médecins Francophones du Canada museum visits prescribed by a primary care physician as a new intervention. Today, it is necessary to improve the knowledge on the effects of this museum visit prescription

The overall objective of this study is to examine the effects of a visit to the MMFA prescribed by a primary care physician on the mental health (well-being and quality of life) of patients living in Montreal.

Enrollment

86 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 18 and over
  • having Internet access at home with an electronic device (computer, keyboard, or smartphone)
  • having no dementia
  • speaking English or French
  • committing to visiting the museum within 3 months of the prescription.

Exclusion criteria

  • individuals participating in a clinical trial at the same time, to avoid interference with the results of the intervention being studied in this protocol
  • individuals with dementia. There are no tests for dementia. The physicians involved in the pre-recruitment process are aware of the cognitive status of their patients. Therefore, they will be able to avoid offering the study to a patient with dementia if such a diagnosis appears in the medical file.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

86 participants in 1 patient group

Intervention
Experimental group
Description:
Physicians participating in the research project will be able to prescribe a visit to the Museum to any of their patients for whom they deem this museum prescription necessary. Only patients who meet the inclusion criteria will be offered to participate in the research. If patients refuse or do not meet the inclusion criteria, they may be prescribed a museum visit but will not be offered the study. After obtaining informed consent, the patient will be asked to complete 2 sets of self-administered questionnaires: in the 2 days prior to the visit and in the 2 days following the MBAM visit.
Treatment:
Other: Museum visit

Trial contacts and locations

1

Loading...

Central trial contact

Olivier Beauchet, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems